Novo Nordisk
Christos A. Nicolaou is an accomplished professional with extensive experience in cheminformatics and digital chemistry across several prominent organizations. Currently serving as Senior Scientific Director and Digital Small Molecule Lead at Novo Nordisk since November 2023, Christos previously held leadership roles at Recursion as Senior Director and Director of Digital Chemistry, and at Eli Lilly and Company as Executive Director and Senior Research Advisor. Christos has expertise in R&D focusing on de novo design, multi-objective optimization, and AI/ML methods for hit identification and lead optimization. The career trajectory also includes strategic consulting roles at Vlassides Winery, scientific coordination at The Cyprus Institute, and contributions as a Senior Scientist at the University of Cyprus. Christos co-founded Noesis Cheminformatics and served as Senior Scientist at Bioreason, Inc. Christos holds a Ph.D. in Computer Science from the University of Cyprus and multiple degrees from Florida State University and the Paedagogical Academy.
Previous companies
This person is not in any teams
This person is not in any offices